Table 2.

Utility value of each patient condition.

Patient condition	Utility value	References
Insulin therapy	0.83 (0.79-0.88)	Sakamaki et al [24]
Insulin therapy + diabetic nephropathy	0.81 (0.72-0.90)	Sakamaki et al [24]
Microalbuminuria	0.81	Sakamaki et al [24], Okubo et al [31]
Macroalbuminuria	0.81	Sakamaki et al [24], Okubo et al [31]
End-stage renal disease	0.81	Sakamaki et al [24], Okubo et al [31]
Cardiovascular events	0.71	Hara et al [25]
Diabetic nephropathy	0.68	Takura et al [26]